Surgalign (SRGA) Stock Forecast, Price Target & Predictions


OverviewOwnershipChart

SRGA Stock Forecast


Surgalign stock forecast is as follows: an average price target of $3.50 (represents a 1813.61% upside from SRGA’s last price of $0.18) and

SRGA Price Target


Surgalign Price Target by Analyst


DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Dec 21, 2022-H.C. Wainwright$3.50$1.36157.35%1813.61%
Row per page
Go to

The latest Surgalign stock forecast, released on Dec 21, 2022 by H.C. Wainwright company, set a price target of $3.50, which represents a 157.35% increase from the stock price at the time of the forecast ($1.36), and a 1813.61% increase from SRGA last price ($0.18).

Surgalign Price Target by Period


1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$0.18$0.18$0.18
Upside/Downside-100.00%-100.00%-100.00%

In the current month, the average price target of Surgalign stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Surgalign's last price of $0.18. This month's average price target is down NaN% compared to last quarter, and down NaN% compared to last year.

Surgalign Peer Comparison by Price Target


TickerCompanyLast Closing PriceAvg Price TargetUpside/DownsideAvg Rating
SRGASurgalign$0.18$3.501844.44%-
APYXApyx Medical$1.16$8.50632.76%Buy
AZYOElutia$1.49$10.25587.92%Buy
INGNInogen$11.33$26.00129.48%Buy
CVRXCVRx$7.85$15.83101.66%Buy
OFIXOrthofix Medical$16.76$31.0084.96%-
ESTAEstablishment Labs$44.20$78.0076.47%Buy
FNAParagon 28$7.39$11.5055.62%Buy
HYPRHyperfine$1.04$1.6053.85%Buy
SIBNSI-BONE$15.73$20.0027.15%Buy
AVNSAvanos Medical$24.00$27.0012.50%Hold
SRDXSurmodics$39.36$39.500.36%Buy
HSCSHeart Test Laboratories$3.04$3.00-1.32%Buy
BVSBioventus$11.17$7.50-32.86%Buy

SRGA Forecast FAQ


According to Wall Street analysts' prediction for SRGA stock, the company can go up by 1813.61% (from the last price of $0.183 to the average price target of $3.5), up by 1813.61% based on the highest stock price target, and up by 1813.61% based on the lowest stock price target.

SRGA's average twelve months analyst stock price target of $3.5 supports the claim that Surgalign can reach $0 in the near future.